SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021686
Filing Date
2020-11-16
Accepted
2020-11-16 16:15:41
Documents
59
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1738723
2 ex31-1.htm EX-31.1 10555
3 ex31-2.htm EX-31.2 10598
4 ex32-1.htm EX-32.1 5783
  Complete submission text file 0001493152-20-021686.txt   6879340

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE aker-20200930.xml EX-101.INS 1104481
6 XBRL SCHEMA FILE aker-20200930.xsd EX-101.SCH 94553
7 XBRL CALCULATION FILE aker-20200930_cal.xml EX-101.CAL 57533
8 XBRL DEFINITION FILE aker-20200930_def.xml EX-101.DEF 288249
9 XBRL LABEL FILE aker-20200930_lab.xml EX-101.LAB 569793
10 XBRL PRESENTATION FILE aker-20200930_pre.xml EX-101.PRE 353956
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 201317104
SIC: 2835 In Vitro & In Vivo Diagnostic Substances